Ferring Pharmaceuticals Announces ESHRE Data Confirming Conventional FSH Dosing for Rekovelle® Matches Follitropin Alfa in IVF

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (fol...

July 03, 2025 | Thursday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
ReproNovo Doses First Participant in Phase 2 Trial of RPN-001, a Novel Oral Therapy for Male Infertility

RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-...

July 02, 2025 | Wednesday | News
Claritev Partners with Fractional AI to Accelerate Responsible GenAI Adoption in Healthcare

Fractional AI, a leading provider of bespoke generative AI solutions, announced a new collaboration with Claritev, formerly known as MultiPlan. This coll...

June 26, 2025 | Thursday | News
Nu Skin Revamps ageLOC® Tru Face® Line with Refillable, Eco-Conscious Packaging

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a r...

June 26, 2025 | Thursday | News
Novadip Biosciences Secures FDA RMAT Designation for NVD003 in Rare Pediatric Bone Disorder

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, announces that the FDA has granted the Regenerative...

June 24, 2025 | Tuesday | News
Alvotech and Advanz Pharma Receive CHMP Positive Opinion for AVT06, a Proposed Biosimilar to Eylea®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

June 24, 2025 | Tuesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News
Lilly’s Once-Weekly Efsitora Matches Daily Insulin in Phase 3 Trials, Global Filing Planned by Year-End

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with...

June 23, 2025 | Monday | Reports
PharmaJet and Immuno Cure Partner to Advance Needle-Free HIV Therapeutic DNA Vaccine with Tropis® ID System

Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...

June 20, 2025 | Friday | News
NeuralCure AI Launches First Diagnostic & Digital Twin OS to Power Patient-Led Healthcare Revolution

NeuralCure AI  announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform...

June 20, 2025 | Friday | News
Draig Therapeutics Launches with $140M to Advance Novel Neuropsychiatric Treatments

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of ...

June 19, 2025 | Thursday | News
Incannex and Mind Medicine Australia Launch Joint Venture to Open Psychedelic Therapies Clinic in Melbourne

Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi...

June 18, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close